223 related articles for article (PubMed ID: 10376440)
1. T cell reactivity to DR*0401- and DQ*0302-binding peptides of the putative autoantigen IA-2 in type 1 diabetes.
Lohmann T; Halder T; Engler J; Morgenthaler NG; Khoo-Morgenthaler UY; Schröder S; Seissler J; Scherbaum WA; Kalbacher H
Exp Clin Endocrinol Diabetes; 1999; 107(3):166-71. PubMed ID: 10376440
[TBL] [Abstract][Full Text] [Related]
2. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
Bonifacio E; Lampasona V; Bingley PJ
J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
[TBL] [Abstract][Full Text] [Related]
3. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.
Roep BO; Atkinson MA; van Endert PM; Gottlieb PA; Wilson SB; Sachs JA
J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen.
Lampasona V; Bearzatto M; Genovese S; Bosi E; Ferrari M; Bonifacio E
J Immunol; 1996 Sep; 157(6):2707-11. PubMed ID: 8805677
[TBL] [Abstract][Full Text] [Related]
5. Enterovirus infection may induce humoral immune response reacting with islet cell autoantigens in humans.
Härkönen T; Paananen A; Lankinen H; Hovi T; Vaarala O; Roivainen M
J Med Virol; 2003 Mar; 69(3):426-40. PubMed ID: 12526055
[TBL] [Abstract][Full Text] [Related]
6. Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens.
Honeyman MC; Stone NL; Falk BA; Nepom G; Harrison LC
J Immunol; 2010 Feb; 184(4):2204-10. PubMed ID: 20083660
[TBL] [Abstract][Full Text] [Related]
7. Humoral and cellular immune responses to proinsulin in adults with newly diagnosed type 1 diabetes.
Narendran P; Williams AJ; Elsegood K; Leech NJ; Dayan CM
Diabetes Metab Res Rev; 2003; 19(1):52-9. PubMed ID: 12592644
[TBL] [Abstract][Full Text] [Related]
8. Increased in vivo frequency of IA-2 peptide-reactive IFNgamma+/IL-4- T cells in type 1 diabetic subjects.
Herzog BA; Ott PA; Dittrich MT; Quast S; Karulin AY; Kalbacher H; Karges W; Tary-Lehmann M; Lehmann PV; Boehm BO; Durinovic-Belló I
J Autoimmun; 2004 Aug; 23(1):45-54. PubMed ID: 15236752
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies and associated T-cell responses to determinants within the 831-860 region of the autoantigen IA-2 in Type 1 diabetes.
Weenink SM; Lo J; Stephenson CR; McKinney PA; Ananieva-Jordanova R; Rees Smith B; Furmaniak J; Tremble JM; Bodansky HJ; Christie MR
J Autoimmun; 2009 Sep; 33(2):147-54. PubMed ID: 19447008
[TBL] [Abstract][Full Text] [Related]
10. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
[TBL] [Abstract][Full Text] [Related]
11. Comparison of IA-2 with IA-2beta and with six other members of the protein tyrosine phosphatase family: recognition of antigenic determinants by IDDM sera.
Notkins AL; Zhang B; Matsumoto Y; Lan MS
J Autoimmun; 1997 Jun; 10(3):245-50. PubMed ID: 9218750
[TBL] [Abstract][Full Text] [Related]
12. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes.
Naserke HE; Ziegler AG; Lampasona V; Bonifacio E
J Immunol; 1998 Dec; 161(12):6963-9. PubMed ID: 9862731
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to IA-2 and IA-2 beta in insulin-dependent diabetes mellitus recognize conformational epitopes: location of the 37- and 40-kDa fragments determined.
Xie H; Zhang B; Matsumoto Y; Li Q; Notkins AL; Lan MS
J Immunol; 1997 Oct; 159(7):3662-7. PubMed ID: 9317167
[TBL] [Abstract][Full Text] [Related]
14. Altered peptide ligands of islet autoantigen Imogen 38 inhibit antigen specific T cell reactivity in human type-1 diabetes.
Geluk A; van Meijgaarden KE; Roep BO; Ottenhoff TH
J Autoimmun; 1998 Aug; 11(4):353-61. PubMed ID: 9776713
[TBL] [Abstract][Full Text] [Related]
15. Identification of peptides from autoantigens GAD65 and IA-2 that bind to HLA class II molecules predisposing to or protecting from type 1 diabetes.
Harfouch-Hammoud E; Walk T; Otto H; Jung G; Bach JF; van Endert PM; Caillat-Zucman S
Diabetes; 1999 Oct; 48(10):1937-47. PubMed ID: 10512357
[TBL] [Abstract][Full Text] [Related]
16. T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes.
Hawkes CJ; Schloot NC; Marks J; Willemen SJ; Drijfhout JW; Mayer EK; Christie MR; Roep BO
Diabetes; 2000 Mar; 49(3):356-66. PubMed ID: 10868956
[TBL] [Abstract][Full Text] [Related]
17. Islet-cell antigen-reactive T cells show different expansion rates and Th1/Th2 differentiation in type 1 diabetic patients and healthy controls.
Ott PA; Herzog BA; Quast S; Hofstetter HH; Boehm BO; Tary-Lehmann M; Durinovic-Bello I; Berner BR; Lehmann PV
Clin Immunol; 2005 Apr; 115(1):102-14. PubMed ID: 15870028
[TBL] [Abstract][Full Text] [Related]
18. T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavirus and other environmental agents.
Honeyman MC; Stone NL; Harrison LC
Mol Med; 1998 Apr; 4(4):231-9. PubMed ID: 9606176
[TBL] [Abstract][Full Text] [Related]
19. ICA512(IA-2) epitope specific assays distinguish transient from diabetes associated autoantibodies.
Miao D; Yu L; Tiberti C; Cuthbertson DD; Rewers M; di Mario U; Eisenbarth GS; Dotta F
J Autoimmun; 2002 Mar; 18(2):191-6. PubMed ID: 11908951
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterisation of a human monoclonal autoantibody to the islet cell autoantigen IA-2.
Ananieva-Jordanova R; Evans M; Nakamatsu T; Premawardhana LD; Sanders J; Powell M; Chen S; McGrath V; Belton C; Arnold C; Baker S; Betterle C; Zanchetta R; Smith BR; Furmaniak J
J Autoimmun; 2005 Jun; 24(4):337-45. PubMed ID: 15869863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
